Format
Items per page

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Venlafaxine

A synthetic phenethylamine bicyclic derivative with antidepressant activity. Venlafaxine and its active metabolite, O-desmethylvenlafaxine (ODV), are potent inhibitors of neuronal serotonin and norepinephrine reuptake and weak dopamine reuptake inhibitors. This agent may reduce hormone-related vasomotor symptoms. (NCI04) [from NCI]

MedGen UID:
36191
Concept ID:
C0078569
Organic Chemical; Pharmacologic Substance
2.

Anxiety

Apprehension of danger and dread accompanied by restlessness, tension, tachycardia, and dyspnea unattached to a clearly identifiable stimulus. [from NCI]

MedGen UID:
1613
Concept ID:
C0003467
Finding; Finding
3.

Generalized anxiety disorder

An anxiety disorder characterized by excessive and difficult-to-control worry about a number of life situations. The worry is accompanied by restlessness, fatigue, inability to concentrate, irritability, muscle tension, and/or sleep disturbance and lasts for at least 6 months. [from NCI]

MedGen UID:
452363
Concept ID:
C0270549
Mental or Behavioral Dysfunction
4.

Anxiety

Human personality is shaped by genetic and environmental factors, and evidence suggests that the genetic component is highly complex, polygenic, and epistatic. Genetic factors are thought to contribute to 40 to 60% of trait variance. Molecular genetics has tried to identify specific genes for quantitative traits, called quantitative trait loci (QTLs). The QTL concept suggests that complex personality traits or dimensions are not attributable to single genes, but to multiple interacting genes (Reif and Lesch, 2003). Fullerton et al. (2003) stated that psychologists were in agreement that the wide variation in human personalities can be explained by a small number of personality factors, including neuroticism (a measure of emotional stability), which manifests at one extreme as anxiety, depression, moodiness, low self-esteem, and diffidence. They cited a number of studies that had described a relationship between high scores on measures of neuroticism and major depressive disorder. They also noted that theoretical studies had suggested that large samples of randomly ascertained sibs could be used to ascertain phenotypically extreme individuals and thereby increase power to detect genetic linkage in complex traits. See also panic disorder (PAND1; 167870), which is a subtype of anxiety disorder. [from GTR]

MedGen UID:
335849
Concept ID:
C1842981
Mental or Behavioral Dysfunction
5.

Generalized

Affecting all regions without specificity of distribution. [from HPO]

MedGen UID:
104661
Concept ID:
C0205246
Spatial Concept
6.

Anxiety disorder

A category of psychiatric disorders which are characterized by anxious feelings or fear often accompanied by physical symptoms associated with anxiety. [from NCI]

MedGen UID:
361
Concept ID:
C0003469
Mental or Behavioral Dysfunction
7.

Possible

Capable of happening or occurring. [from NCI]

MedGen UID:
137646
Concept ID:
C0332149
Finding
8.

Examined for

Having been subjected to inspection or evaluation. [from NCI]

MedGen UID:
83047
Concept ID:
C0332128
Finding
9.

HTLV-1-associated myelopathy-tropical spastic paraparesis

A progressive chronic inflammatory disease of the central nervous system with the aetiologic agent Human T cell lymphotropic virus type I (HTLV-I), the disease is characterised by unremitting myelopathic symptoms such as spastic paraparesis, bowel and/or bladder dysfunction and sensory changes of the lower limbs. [from SNOMEDCT_US]

MedGen UID:
18298
Concept ID:
C0030481
Disease or Syndrome
10.

Antidepressant

A pharmacological agent that acts on neurotransmitter signaling pathways to alleviate the symptoms of depression. [from NCI]

MedGen UID:
1588
Concept ID:
C0003289
Pharmacologic Substance
11.

Biomarkers, Pharmacological

Measurable biological parameters that serve for drug development, safety and dosing (DRUG MONITORING). [from MeSH]

MedGen UID:
408203
Concept ID:
C1955886
Pharmacologic Substance
12.

Sila-Venlafaxine

MedGen UID:
354594
Concept ID:
C1721158
Organic Chemical; Pharmacologic Substance
13.

Dobupal

MedGen UID:
280105
Concept ID:
C1529224
Organic Chemical; Pharmacologic Substance
14.

Anxiety neurosis

Term was discontinued in 1997. In 2000, the term was removed from all records containing it, and replaced with ANXIETY DISORDERS, its postable counterpart. [from PSY]

MedGen UID:
226912
Concept ID:
C1279420
Mental or Behavioral Dysfunction
15.

Venlafaxine hydrochloride

A cyclohexanol and phenylethylamine derivative that functions as a SEROTONIN AND NORADRENALINE REUPTAKE INHIBITOR (SNRI) and is used as an ANTIDEPRESSIVE AGENT. [from MeSH]

MedGen UID:
162695
Concept ID:
C0771200
Organic Chemical; Pharmacologic Substance
16.

Diagnosis, Psychiatric

MedGen UID:
138165
Concept ID:
C0376338
Mental or Behavioral Dysfunction
17.

Effexor

a kind of depression treatment drug [from CHV]

MedGen UID:
108494
Concept ID:
C0591437
Organic Chemical; Pharmacologic Substance
18.

Psychotherapeutic agent

A classification of medication that acts on the central nervous system, affecting brain function, level of consciousness, mood, emotions, and behavior. [from NCI]

MedGen UID:
46201
Concept ID:
C0033978
Pharmacologic Substance
19.

Thymoanaleptics

MedGen UID:
21538
Concept ID:
C0040094
Pharmacologic Substance
20.

Thymoleptics

MedGen UID:
21167
Concept ID:
C0040098
Pharmacologic Substance
Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center